欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > GPCR/GProtein > Evatanepag

浏览历史

S84506

Evatanepag

源叶(MedMol) 98%
  • 英文名:
  • Evatanepag
  • 别名:
  • UNII-L266R6E31E; CP-533,536; Evatanepag;
  • CAS号:
  • 223488-57-1
  • 分子式:
  • C25H28N2O5S
  • 分子量:
  • 468.5652
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S84506-1mg 98% ¥816.00元 >10 - - - EA 加入购物车
源叶(MedMol) S84506-5mg 98% ¥1904.00元 >10 - - - EA 加入购物车
源叶(MedMol) S84506-10mg 98% ¥3100.00元 >10 - - - EA 加入购物车
源叶(MedMol) S84506-25mg 98% ¥5100.00元 >10 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Evatanepag (CP-533536) is a non-prostanoid, potent and selective EP2 receptor agonist. Evatanepag can induce local bone formation in vivo. Evatanepag can be used in the research of fractures, bone defects, asthma
  • 靶点: EP2;ProstaglandinReceptor
  • 体外研究:
    Evatanepag (10 nM, 30 min) inhibits hFcεRI-induced mast cells degranulation in a dose-dependent manner. Evatanepag (0.1 nM-10 μM, 12 min) results in an equivalent increase in intracellular cAMP in HEK-293 cells, with an IC50 of 50 nM
  • 体内研究:
    Evatanepag (0.3-3.0 mg/kg, directly injected into the marrow cavity of the tibia) promotes bone formation in rats. Evatanepag (0.3, 3.0 mg/kg, intranasal administration, from day1 to day4) reduces HDM aeroallergen-induced increased RL response to methacholine in mice. Evatanepag (1 mg/kg, intravenous injection) demonstrates high i.v. clearance (Cl: 56 mL/min/kg) and a short half-life (t1/2: 0.33 h). Animal Model: Rats Dosage: 0.3, 1.0, 3.0 mg/kg Administration: Directly injected into the marrow cavity of the tibia Result: Dose-dependently increased in bone area, bone mineral content, bone mineral density. Animal Model: HDM (house dust mite)-sensitized BALB/c mice Dosage: 0.3 mg/kg, 3 mg/kg Administration: Intranasal administration, from day1 to day4 Result: Prevented aeroallergen-driven increased RL (lung resistance) at 0.3 mg/kg.Prevented the enhanced MC activity by approximately 48% at 3 mg/kg.
  • 参考文献:
    1. Cameron KO, et al. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. Bioorg Med Chem Lett. 2009 Apr 1;19(7):2075-8. 2. Judith Plaza, et al. In Vitro and In Vivo Validation of EP2-Receptor Agonism to Selectively Achieve Inhibition of Mast Cell Activity. Allergy Asthma Immunol Res. 2020 Jul;12(4):712-728. 3. V M Paralkar, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6736-40.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.134 ml 10.671 ml 21.342 ml
    5 mM 0.427 ml 2.134 ml 4.268 ml
    10 mM 0.213 ml 1.067 ml 2.134 ml
    50 mM 0.043 ml 0.213 ml 0.427 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。